Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06494722 · ClinicalTrials.gov registry record · NA

Expansion of the T1DES Pilot to a Public Hospital

A NA study of Type 1 Diabetes, sponsored by Kaiser Permanente.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06494722 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Kaiser Permanente. The registered enrollment target is 40 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06494722, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Kaiser Permanente.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailored intervention T1DES and evaluates the effect of the T1DES intervention on diabetes outcomes in a pilot randomized clinical trial among Black young adults with T1D.

Conditions Studied

Interventions

  • BEHAVIORAL Diabetes Education
  • BEHAVIORAL T1DES

Study Locations (1)

Georgia

  • Grady Health System - Atlanta

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-25
Est. Completion 2025-11-30
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT06494722

The ClinicalTrials.gov registry entry for NCT06494722 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Diabetes Education is the first listed.

NCT06494722 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06494722 about?

NCT06494722 is a clinical study titled "Expansion of the T1DES Pilot to a Public Hospital". Diabetes distress has been identified as one of the largest contributors to the racial disparity in glycemic control that disproportionately burdens Black patients ages 18-30 years with type 1 diabetes (T1D). In order to combat this issue, this study assesses the feasibility of the culturally tailor...

What is the current status of trial NCT06494722?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-25. Estimated completion is 2025-11-30.

What conditions does trial NCT06494722 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT06494722?

The interventions under investigation include: Diabetes Education (BEHAVIORAL), T1DES (BEHAVIORAL).

Who is sponsoring clinical trial NCT06494722?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06494722 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.